News

BioPoly LLC has announced that another U.S. patent has been granted for its innovative BioPoly® material, which is currently being used to replace damaged cartilage in joints.

FORT WAYNE, IN – BioPoly LLC has announced that another U.S. patent has been granted for its partial resurfacing implants.

FORT WAYNE, IN – BioPoly, LLC has entered into an exclusive distribution agreement with UK-based distributor, Hospital Innovations Ltd, to distribute the BioPoly® partial resurfacing family of products throughout the UK.

FORT WAYNE, IN – BioPoly LLC has announced that another European patent has been granted for its partial resurfacing implants. Where many of the other BioPoly® patents address the unique material, this patent family focuses on the innovative implant designs.

FORT WAYNE, IN – BioPoly has just announced that the US FDA has approved an IDE clinical study for its BioPoly® RS Partial Resurfacing Knee System. The BioPoly knee is used to treat patients with painful cartilage lesions by filling the defect with its proprietary implant material known as BioPoly. According to the Company, initiation of the clinical study in the US will happen soon.

FORT WAYNE, IN – BioPoly has just announced that its BioPoly® RS Partial Resurfacing Trochlea System is now CE marked, expanding the implant offering of the BioPoly® RS Partial Resurfacing portfolio. With the addition of the RS Trochlea implants, the BioPoly® RS Partial Resurfacing Knee System now offers treatment options for focal cartilage defects in the femoral condyles, trochlear facets, trochlear groove, and patella.